Jul 2026
Cycloastragenol overcomes trastuzumab resistance in HER2-positive breast cancer by regulating cell cycle and epithelial-mesenchymal transition through EZH2/PTEN/AKT pathway.
CAG modulates the cell cycle and EMT through the EZH2/PTEN/AKT pathway, effectively overcoming Tmab resistance in HER2-positive BC cells.
Ming-yuan Wu, Fenggang Hou, Zhaoshuo Yang et al.
· Naunyn-Schmiedeberg's Archiv... · 0 citations